logo

DMAA

Drugs Made In·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
4.21 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Will DMAA Go Up?
  • Based on a composite score of 4.21/10, we rate DMAA as a Netural. Our analysis breaks down into 2.69/10 for Fundamentals, 4.38/10 for Technicals, and 5.57/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is DMAA fundamentally strong?
What is the current technical signals for DMAA?
What is the analyst consensus for DMAA?